Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 2, 2021, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

26.50

Change

+0.60 +2.32%

Volume

Volume 288,588

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Today's close

$ 25.56

$ 25.90

Change

+0.34 +1.33%

Day low

Day high

$25.47

$29.60

Open

52 week low

52 week high

$2.43

$67.00

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/23/2021 Michael B. Shtender-Auerbach
Director
5,929   0
02/23/2021 Michael B. Shtender-Auerbach
Director
20,392   0
02/23/2021 Michael B. Shtender-Auerbach
Director
89,349   0
02/23/2021 Michael B. Shtender-Auerbach
Director
228,433   0
02/19/2021 Jon Levin
Chief Operating Officer
26,982   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Michael Kruteck
Chief Financial Officer
23,476   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2021 Jon Levin
Chief Operating Officer
56,738   Award at $0 per share. 0
02/19/2021 Michael Kruteck
Chief Financial Officer
53,191   Award at $0 per share. 0
01/25/2021 Brendan Kennedy
President and CEO; Director
57   0
01/25/2021 Brendan Kennedy
President and CEO; Director
3,371   0
01/25/2021 Michael B. Shtender-Auerbach
Director
202   0
01/25/2021 Michael B. Shtender-Auerbach
Director
517   0
01/25/2021 Michael B. Shtender-Auerbach
Director
116   0
01/01/2021 Brendan Kennedy
President and CEO; Director
12,777   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Michael B. Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
3,595   0
12/18/2020 Michael B. Shtender-Auerbach
Director
13,895   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
7,497   Derivative/Non-derivative trans. at $0 per share. 0
12/18/2020 Michael B. Shtender-Auerbach
Director
61,289   0
12/18/2020 Michael B. Shtender-Auerbach
Director
156,693   0
12/18/2020 Andrew Pucher
Chief Corporate Dev Officer
3,303   Derivative/Non-derivative trans. at $0 per share. 0
12/16/2020 Christine Thompson St. Clare
Director
2,200   Disposition at $10 per share. 22,000
12/01/2020 Rebekah Dopp
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2020 Christine Thompson St. Clare
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
11/10/2020 Brendan Kennedy
President and CEO; Director
380,781   Derivative/Non-derivative trans. at $7.76 per share. 2,954,860
11/06/2020 Brendan Kennedy
President and CEO; Director
2,127   Disposition at $11.71 per share. 24,907
11/06/2020 Brendan Kennedy
President and CEO; Director
118,852   Disposition at $10.72 per share. 1,274,093
11/06/2020 Brendan Kennedy
President and CEO; Director
148,933   Disposition at $9.96 per share. 1,483,372
11/06/2020 Brendan Kennedy
President and CEO; Director
130,088   Disposition at $9 per share. 1,170,792
11/06/2020 Rebekah Dopp
Director
4,812   Disposition at $10 per share. 48,120
11/06/2020 Christine Thompson St. Clare
Director
4,400   Disposition at $10.05 per share. 44,220
11/05/2020 Brendan Kennedy
President and CEO; Director
127,213   Disposition at $7.76 per share. 987,172
11/05/2020 Brendan Kennedy
President and CEO; Director
272,787   Disposition at $7.28 per share. 1,985,889

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
9 Purchases
14 Sales
210,299
608,765
Last 6 months
20 Purchases
31 Sales
9,099,869
4,248,448
Last 12 months
51 Purchases
57 Sales
9,663,336
6,824,255

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Mr. Andrew Pucher
Chief Corporate Development Officer
Ms. Rita Seguin
Chief Human Resources Officer
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Mr. Soren W. Schroder
Independent Director
Ms. Christine Thompson St. Clare
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael B. Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.